MERSANA THERAPEUTICS INC's ticker is MRSN and the CUSIP is 59045L106. A total of 130 filers reported holding MERSANA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.05 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $111 | -71.8% | 87,113 | -27.0% | 0.00% | – |
| Q2 2023 | $394 | -21.2% | 119,345 | -1.7% | 0.00% | – |
| Q1 2023 | $500 | -29.3% | 121,377 | +0.7% | 0.00% | – |
| Q4 2022 | $707 | -99.9% | 120,519 | +7.6% | 0.00% | – |
| Q3 2022 | $758,000 | +17.3% | 112,039 | -19.9% | 0.00% | – |
| Q2 2022 | $646,000 | +17.2% | 139,819 | +1.3% | 0.00% | – |
| Q1 2022 | $551,000 | -22.6% | 138,034 | +20.6% | 0.00% | – |
| Q4 2021 | $712,000 | -92.3% | 114,447 | -88.3% | 0.00% | -100.0% |
| Q3 2021 | $9,250,000 | -70.6% | 980,896 | -57.7% | 0.00% | -66.7% |
| Q2 2021 | $31,475,000 | -34.6% | 2,317,747 | -22.1% | 0.00% | -40.0% |
| Q1 2021 | $48,121,000 | -45.3% | 2,974,087 | -10.0% | 0.01% | -44.4% |
| Q4 2020 | $87,929,000 | +158.2% | 3,304,346 | +80.7% | 0.01% | +125.0% |
| Q3 2020 | $34,049,000 | +95.3% | 1,828,619 | +145.4% | 0.00% | +100.0% |
| Q2 2020 | $17,438,000 | – | 745,220 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RHO CAPITAL PARTNERS INC | 796,458 | $4,564,000 | 3.47% |
| NEA Management Company, LLC | 11,963,649 | $68,552,000 | 3.24% |
| Sarissa Capital Management LP | 3,750,000 | $21,487,000 | 1.78% |
| VHCP Management III, LLC | 1,561,389 | $8,947,000 | 1.78% |
| VHCP Management II, LLC | 922,514 | $5,286,000 | 1.39% |
| Ghost Tree Capital, LLC | 800,000 | $4,584,000 | 0.87% |
| BVF INC/IL | 1,180,553 | $6,765,000 | 0.51% |
| Sio Capital Management, LLC | 166,250 | $953,000 | 0.23% |
| Rock Springs Capital Management LP | 1,233,000 | $7,065,000 | 0.22% |
| DAFNA Capital Management LLC | 108,463 | $621,000 | 0.21% |